Drug Shortage Report for MOUNJARO
Report ID | 210461 |
Drug Identification Number | 02541092 |
Brand name | MOUNJARO |
Common or Proper name | tirzepatide injection |
Company Name | ELI LILLY CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | |
Strength(s) | 12.5MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 3 mL single-dose vial |
ATC code | A10BX |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-12-15 |
Actual start date | 2023-12-15 |
Estimated end date | 2024-12-02 |
Actual end date | 2024-12-02 |
Shortage status | Resolved |
Updated date | 2024-12-03 |
Company comments | For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2024-12-03 | French | Compare |
v17 | 2024-12-03 | English | Compare |
v16 | 2024-08-30 | French | Compare |
v15 | 2024-08-30 | English | Compare |
v14 | 2024-05-09 | French | Compare |
v13 | 2024-05-09 | English | Compare |
v12 | 2024-02-22 | French | Compare |
v11 | 2024-02-22 | English | Compare |
v10 | 2024-02-02 | French | Compare |
v9 | 2024-02-02 | English | Compare |
v8 | 2023-12-16 | English | Compare |
v7 | 2023-12-15 | French | Compare |
v6 | 2023-12-15 | English | Compare |
v5 | 2023-12-11 | French | Compare |
v4 | 2023-12-11 | English | Compare |
v3 | 2023-12-10 | English | Compare |
v2 | 2023-11-17 | French | Compare |
v1 | 2023-11-17 | English | Compare |
Showing 1 to 18 of 18